Foresight Acquisition filed a proxy statement outlining details of its proposed merger with P3 Health Partners. The deal values the combined company at $2.3 billion. A shareholder vote is set for Nov. 18.
Announced in May, proceeds would consist of up to $316 million of cash held in Foresight’s trust, assuming no redemptions, and an additional $200 million PIPE, including participation from funds and accounts managed by Fidelity Management & Research Company and Janus Henderson Investors.
P3 is a physician-led population health management company that supports providers, physicians, and practices in value-based systems of care and wellness. P3 is a portfolio company of Chicago Pacific Founders who provided P3’s initial and growth capital.
Pending regulatory and shareholder approvals, upon closing P3 Health Partners would list on the Nasdaq. Read more.Share
